160,95 €
160,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
80 °P sammeln
160,95 €
160,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
80 °P sammeln
Als Download kaufen
160,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
80 °P sammeln
Jetzt verschenken
160,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
80 °P sammeln
  • Format: PDF

Contains the latest information on the subject of neuropsychiatric disorders in relation to 5-HT2A Reflects on various factors involved in normal and pathological behavior Provides practical suggestions¿

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 10.18MB
Produktbeschreibung
Contains the latest information on the subject of neuropsychiatric disorders in relation to 5-HT2A
Reflects on various factors involved in normal and pathological behavior
Provides practical suggestions¿

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Giuseppe Di Giovanni is Professor of Human Physiology, University of Malta, Malta. He is the President of the Malta Neuroscience Network and the Vice-President of the Mediterranean Neuroscience Society. He is the Editor in  Chief of Journal Neuroscience Methods by Elsevier and the Editor for the book series The Receptor by Springer/Nature. His research  focuses on the pathophysiology of the monoaminergic systems in different neuropsychiatric disorders, such as Parkinson's disease, depression, drug of abuse and epilepsy. Bruno Guiard is Associate Professor in Pharmacology, University of Paris XI, France. He is the author of several book chapters/reviews on the mechanisms of action of antidepressant drugs. He also took part in the edition of books on the neurobiology of mood. His research deals with the influence of astroglial cells in the regulation of serotonergic neurotransmission and the identification of new pharmacological targets for the treatment of various neuropsychiatric diseases.